Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene ... new ...
Joseph Schwartz, an analyst from Leerink Partners, reiterated the Hold rating on PTC Therapeutics (PTCT – Research Report). The ...
Barclays raised the firm’s price target on PTC Therapeutics (PTCT) to $43 from $31 and keeps an Equal Weight rating on the shares. The ...
Industrial software maker PTC forecast first-quarter revenue below estimates on Wednesday, signaling continued weakness in ...
For the quarter, PTC anticipates revenues to be between $598 million and $648 million. Non-GAAP earnings per share (EPS) are expected to be between $1.30 and $1.66. The Zacks Consensus Estimate ...
BOSTON (AP) — BOSTON (AP) — PTC Inc. (PTC) on Wednesday reported fiscal fourth-quarter profit of $126.5 million. The Boston-based company said it had profit of $1.04 per share. Earnings ...
Berenberg downgraded PTC (PTC, Financials) to hold from buy on Friday, citing a lack of stabilization in key markets that have continued to experience macroeconomic challenges, particularly aerospace, ...
PTC Forecasts Quarterly Revenue Below Estimates on Tight Tech Spending (Reuters) - Industrial software maker PTC forecast first-quarter revenue below estimates on Wednesday, signaling continued ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback